[Morphine sulfate per os combined with octreotide in continuous peridural therapy in oncologic pain. Description of a clinical case].
The authors emphasize the analgesic synergy of the association of morphina sulphate per os and octreotide in continuous epidural therapy in a patient affected by a late prostatic cancer with diffuse skeletal metastases. They, moreover, support cenesthesia regulating and, perhaps, antiproliferative activity of octreotide. A few patients treated with octreotide in continuous epidural therapy showed neurological diseases of behaviour.
Reverberi
C
C
Divisione di Medicina I, USL n. 14 Modena, Ospedale di Carpi, Modena.
Artioli
F
F
Di Donato
C
C
Guaitoli
T
T
Carapezzi
C
C
D000284:Administration, Oral; D015360:Analgesia, Epidural; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage; D009369:Neoplasms / Q000150:complications*; D015282:Octreotide; D010146:Pain / Q000188:drug therapy* / Q000209:etiology
D009020:Morphine; D015282:Octreotide
Associazione morfina solfato per os-octreotide in peridurale continua nel dolore oncologico. Descrizione di un caso clinico.